These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32072403)

  • 1. Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.
    Mahdiannasser M; Haghpanah V; Damavandi E; Kabuli M; Tavangar SM; Larijani B; Ghadami M
    Mol Biol Rep; 2020 Mar; 47(3):2161-2169. PubMed ID: 32072403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter methylation in overexpression of CITED1 in papillary thyroid cancer.
    Sassa M; Hayashi Y; Watanabe R; Kikumori T; Imai T; Kurebayashi J; Kiuchi T; Murata Y
    Thyroid; 2011 May; 21(5):511-7. PubMed ID: 21449767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
    Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.
    Moraes L; Galrão AL; Rubió I; Cerutti JM
    Oncotarget; 2016 May; 7(18):25960-70. PubMed ID: 27036019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
    Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
    Li JY; Han C; Zheng LL; Guo MZ
    Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
    Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
    Avin BA; Wang Y; Gilpatrick T; Workman RE; Lee I; Timp W; Umbricht CB; Zeiger MA
    Genes Chromosomes Cancer; 2019 Aug; 58(8):530-540. PubMed ID: 30664813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression.
    Scarpino S; Di Napoli A; Rapazzotti-Onelli M; Pilozzi E; Ruco L
    Br J Cancer; 2004 Aug; 91(4):703-6. PubMed ID: 15266330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor-promoting function of ECRG4 in papillary thyroid carcinoma and its related mechanism.
    Chen J; Liu C; Yin L; Zhang W
    Tumour Biol; 2015 Feb; 36(2):1081-9. PubMed ID: 25326809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
    Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
    J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer.
    Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M
    Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN promoter methylation in sporadic thyroid carcinomas.
    Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
    Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma.
    Schagdarsurengin U; Gimm O; Dralle H; Hoang-Vu C; Dammann R
    Thyroid; 2006 Jul; 16(7):633-42. PubMed ID: 16889486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.